FrancophonIA/ELRC3.0 huggingface dataset:
English: When measured by ambulatory blood pressure monitoring, the trough to peak effects of Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg were 100%.
Romanian: În determinările efectuate în cadrul monitorizării ambulatorii a tensiunii arteriale, diferenţa dintre efectul înaintea dozei următoare şi efectul maxim al Irbesartan Hydrochlorothiazide BMS 150 mg/12,5 mg a fost de 100%.
English: The combination of 300 mg irbesartan and 12.5 mg hydrochlorothiazide resulted in an overall placebo-subtracted systolic/diastolic reductions of up to 13.6/11.5 mm Hg.
Romanian: Asocierea de 300 mg irbesartan şi 12,5 mg hidroclorotiazidă a permis o scădere globală a tensiunii arteriale sistolice/diastolice de până la 13,6/11,5 mm Hg comparativ cu placebo.
English: The usual dose of Irbesartan Hydrochlorothiazide BMS is one tablet a day.
Romanian: Doza uzuală de Irbesartan Hydrochlorothiazide BMS este de un comprimat o dată pe zi.
English: The addition of 12.5 mg hydrochlorothiazide to 300 mg irbesartan once daily in patients not adequately controlled on 300 mg irbesartan alone resulted in further placebo-corrected diastolic blood pressure reductions at trough (24 hours post-dosing) of 6.1 mm Hg.
Romanian: Adăugarea a 12,5 mg hidroclorotiazidă la 300 mg irbesartan, administrat o dată pe zi, la pacienţii insuficient controlaţi terapeutic cu 300 mg irbesartan în monoterapie, a dus la o scădere suplimentară a tensiunii arteriale diastolice înaintea dozei următoare (după 24 ore de la administrare), cu cel puţin 6,1 mm Hg în plus comparativ cu placebo.
English: Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg may be administered in patients insufficiently controlled by Irbesartan Hydrochlorothiazide BMS 300 mg/12.5 mg.
Romanian: Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg poate fi administrat la pacienţii insuficient controlaţi terapeutic cu Irbesartan Hydrochlorothiazide BMS 300 mg/12,5 mg.
English: Lactose monohydrate Microcrystalline cellulose Croscarmellose sodium Pregelatinized starch Silicon dioxide Magnesium stearate Red and yellow ferric oxides
Romanian: Lactoză monohidrat Celuloză microcristalină Croscarmeloză sodică Amidon pregelatinizat Dioxid de siliciu Stearat de magneziu Oxizi roşu şi galben de fer
English: MARKETING AUTHORISATION NUMBERS EU/1/06/369/001-005
Romanian: NUMĂRUL(ELE) AUTORIZAŢIEI DE PUNERE PE PIAŢĂ EU/1/06/369/001-005
English: Irbesartan Hydrochlorothiazide BMS 300 mg/12.5 mg may be administered in patients insufficiently controlled by irbesartan 300 mg or by Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg.
Romanian: Irbesartan Hydrochlorothiazide BMS 300 mg/12,5 mg poate fi administrat la pacienţii insuficient controlaţi terapeutic cu irbesartan 300 mg sau cu Irbesartan Hydrochlorothiazide BMS 150 mg/12,5 mg.
English: INFORMATION IN BRAILLE Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg
Romanian: INFORMAŢII ÎN BRAILLE Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg
English: Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg may be administered in patients whose blood pressure is not adequately controlled with hydrochlorothiazide or irbesartan 150 mg alone;
Romanian: Irbesartan Hydrochlorothiazide BMS 150 mg/12,5 mg poate fi administrat la pacienţii a căror tensiune arterială nu este controlată adecvat cu hidroclorotiazidă sau cu irbesartan 150 mg, în monoterapie.
English: MARKETING AUTHORISATION NUMBERS EU/1/06/369/017-022
Romanian: NUMĂRUL(ELE) AUTORIZAŢIEI DE PUNERE PE PIAŢĂ EU/1/06/369/017-022
English: MARKETING AUTHORISATION NUMBERS EU/1/06/369/006-010
Romanian: NUMĂRUL(ELE) AUTORIZAŢIEI DE PUNERE PE PIAŢĂ EU/1/06/369/006-010
English: MARKETING AUTHORISATION NUMBERS EU/1/06/369/011-016
Romanian: NUMĂRUL(ELE) AUTORIZAŢIEI DE PUNERE PE PIAŢĂ EU/1/06/369/011-016
English: STATEMENT OF ACTIVE SUBSTANCES Each tablet contains: irbesartan 150 mg and hydrochlorothiazide 12.5 mg
Romanian: DECLARAREA SUBSTANŢELOR ACTIVE Fiecare comprimat conţine: irbesartan 150 mg şi hidroclorotiazidă 12,5 mg
English: MARKETING AUTHORISATION NUMBERS EU/1/06/369/023-028
Romanian: NUMĂRUL(ELE) AUTORIZAŢIEI DE PUNERE PE PIAŢĂ EU/1/06/369/023-028
English: Lithium: reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with angiotensin converting enzyme inhibitors.
Romanian: Litiu: în timpul tratamentului care asociază litiul cu inhibitori ai enzimei de conversie a angiotensinei, s-au raportat creşteri reversibile ale concentraţiilor plasmatice şi ale toxicităţii litiului.
English: STATEMENT OF ACTIVE SUBSTANCES Each tablet contains: irbesartan 300 mg and hydrochlorothiazide 25 mg
Romanian: DECLARAREA SUBSTANŢELOR ACTIVE Fiecare comprimat conţine: irbesartan 300 mg şi hidroclorotiazidă 25 mg
English: INFORMATION IN BRAILLE Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg
Romanian: INFORMAŢII ÎN BRAILLE Irbesartan Hydrochlorothiazide BMS 150 mg/12,5 mg
English: Each film-coated tablet of Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg contains 300 mg irbesartan and 25 mg hydrochlorothiazide.
Romanian: Fiecare comprimat filmat de Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg conţine irbesartan 300 mg şi hidroclorotiazidă 25 mg.
English: INFORMATION IN BRAILLE Irbesartan Hydrochlorothiazide BMS 300 mg/12.5 mg
Romanian: INFORMAŢII ÎN BRAILLE Irbesartan Hydrochlorothiazide BMS 300 mg/12,5 mg
English: STATEMENT OF ACTIVE SUBSTANCES Each tablet contains: irbesartan 300 mg and hydrochlorothiazide 12.5 mg
Romanian: DECLARAREA SUBSTANŢELOR ACTIVE Fiecare comprimat conţine: irbesartan 300 mg şi hidroclorotiazidă 12,5 mg
English: Cartons of 56 x 1 film-coated tablets; 7 blister cards of 8 x 1 film-coated tablets each in PVC/PVDC/Aluminium perforated unit dose blisters.
Romanian: Cutie cu 56 x 1 comprimate filmate, card cu 7 blistere perforate pentru eliberarea unei unităţi dozate din PVC/PVDC/Aluminiu a câte 8 comprimate filmate.
English: The PSUR cycle of Irbesartan Hydrochlorothiazide BMS is aligned with the cross-referred product, KARVEZIDE, until otherwise specified.
Romanian: Atunci când nu este o altă recomandare, ciclul RPAS al Irbesartan Hydrochlorothiazide BMS este aliniat cu cel al produsului de referinţă KARVEZIDE.
English: Efficacy and safety of Irbesartan Hydrochlorothiazide BMS as initial therapy for severe hypertension (defined as SeDBP ≥ 110 mmHg) was evaluated in a multicenter, randomized, double-blind, active controlled, 8-week, parallel-arm study.
Romanian: Într-un studiu cu durata de 8 săptămâni, multicentric, randomizat, dublu-orb, controlat activ, s-a studiat eficacitatea şi siguranţa Irbesartan Hydrochlorothiazide BMS ca şi terapie iniţială pentru hipertensiunea arterială severă (definită prin valoarea tensiunii arteriale diastolice > 110 mmHg).
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 300 mg of irbesartan and 25 mg of hydrochlorothiazide.
Romanian: COMPOZIŢIA CALITATIVĂ ŞI CANTITATIVĂ Fiecare comprimat filmat conţine irbesartan 300 mg şi hidroclorotiazidă 25 mg. Excipient:
English: Marketing Authorisation Holder BRISTOL-MYERS SQUIBB PHARMA EEIG Uxbridge Business Park Sanderson Road
Romanian: Deţinătorul autorizaţiei de punere pe piaţă şi producătorul BRISTOL-MYERS SQUIBB PHARMA EEIG Uxbridge Business Park
English: Cartons of 84 film-coated tablets; 6 blister cards of 14 film-coated tablets in PVC/PVDC/Aluminium blisters.
Romanian: Cutie cu 84 comprimate filmate; card cu 6 blistere din PVC/PVDC/Aluminiu a câte 14 comprimate filmate.
English: Cartons of 56 x 1 tablets; 7 blister cards of 8 x 1 tablets each in PVC/PVDC/Aluminium perforated unit dose blisters.
Romanian: Cutie cu 56 x 1 comprimate, card cu 7 blistere perforate pentru eliberarea unei unităţi dozate din PVC/PVDC/Aluminiu a câte 8 comprimate.
English: Cartons of 14 tablets; 1 blister card of 14 tablets in PVC/PVDC/Aluminium blisters.
Romanian: Cutie cu 14 comprimate; card cu 1 blister din PVC/PVDC/Aluminiu a 14 comprimate.
English: While this is not documented with Irbesartan Hydrochlorothiazide BMS, a similar effect should be anticipated.
Romanian: Poate fi anticipat un efect similar pentru Irbesartan Hydrochlorothiazide BMS, cu toate că nu a fost dovedit.
English: EU/1/06/369/017 - 14 tablets EU/1/06/369/018 - 28 tablets EU/1/06/369/019 - 56 tablets EU/1/06/369/020 - 56 x 1 tablets EU/1/06/369/021 - 84 tablets EU/1/06/369/022 - 98 tablets
Romanian: EU/1/06/369/017 - 14 comprimate EU/1/06/369/018 - 28 comprimate EU/1/06/369/019 - 56 comprimate EU/1/06/369/020 - 56 x 1 comprimate EU/1/06/369/021 - 84 comprimate EU/1/06/369/022 - 98 comprimate
English: EU/1/06/369/011 - 14 tablets EU/1/06/369/012 - 28 tablets EU/1/06/369/013 - 56 tablets EU/1/06/369/014 - 56 x 1 tablets EU/1/06/369/015 - 84 tablets EU/1/06/369/016 - 98 tablets
Romanian: EU/1/06/369/011 - 14 comprimate EU/1/06/369/012 - 28 comprimate EU/1/06/369/013 - 56 comprimate EU/1/06/369/014 - 56 x 1 comprimate EU/1/06/369/015 - 84 comprimate EU/1/06/369/016 - 98 comprimate
English: Once daily dosing with 150 mg irbesartan and 12.5 mg hydrochlorothiazide gave systolic/diastolic mean placebo-adjusted blood pressure reductions at trough (24 hours post-dosing) of 12.9/6.9 mm Hg in patients with mild-to-moderate hypertension.
Romanian: La pacienţii cu hipertensiune arterială uşoară până la moderată, administrarea zilnică, în priză unică, de 150 mg irbesartan şi 12,5 mg hidroclorotiazidă a permis o scădere medie comparativ cu placebo de 12,9/6,9 mm Hg a tensiunii arteriale sistolice/diastolice înaintea dozei următoare (după 24 ore de la administrare).
English: Cartons of 28 tablets; 2 blister cards of 14 tablets in PVC/PVDC/Aluminium blisters.
Romanian: Cutie cu 28 comprimate; card cu 2 blistere din PVC/PVDC/Aluminiu a câte 14 comprimate.
English: Renal impairment: in patients with renal impairment or those undergoing haemodialysis, the pharmacokinetic parameters of irbesartan are not significantly altered.
Romanian: Insuficienţă renală: parametrii farmacocinetici ai irbesartanului nu sunt semnificativ modificaţi la pacienţii cu insuficienţă renală sau la cei hemodializaţi.
English: Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg film-coated tablets are supplied in blister packs of 14, 28, 56, 84 or 98 film-coated tablets.
Romanian: Comprimatele filmate de Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg sunt disponibile în cutii cu blistere care conţin 14, 28, 56, 84 sau 98 de comprimate filmate.
English: cough
Romanian: KGAA
English: Cartons of 28 film-coated tablets; 2 blister cards of 14 film-coated tablets in PVC/PVDC/Aluminium blisters.
Romanian: Cutie cu 28 comprimate filmate; card cu 2 blistere din PVC/PVDC/Aluminiu a câte 14 comprimate filmate.
English: EU/1/06/369/023 - 14 tablets EU/1/06/369/024 - 28 tablets EU/1/06/369/025 - 56 tablets EU/1/06/369/026 - 56 x 1 tablets EU/1/06/369/027 - 84 tablets EU/1/06/369/028 - 98 tablets
Romanian: EU/1/06/369/023 - 14 comprimate EU/1/06/369/024 - 28 comprimate EU/1/06/369/025 - 56 comprimate EU/1/06/369/026 - 56 x 1 comprimate EU/1/06/369/027 - 84 comprimate EU/1/06/369/028 - 98 comprimate
English: Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg film-coated tablets are supplied in blister packs of 14, 28, 56, 84 or 98 film-coated tablets.
Romanian: Comprimatele filmate de Irbesartan Hydrochlorothiazide BMS 150 mg/12,5 mg sunt disponibile în cutii cu blistere care conţin 14, 28, 56, 84 sau 98 de comprimate filmate.
English: Cartons of 14 film-coated tablets; 1 blister card of 14 film-coated tablets in PVC/PVDC/Aluminium blisters.
Romanian: Cutie cu 14 comprimate filmate; card cu 1 blister din PVC/PVDC/Aluminiu a 14 comprimate filmate.
English: Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets.
Romanian: Comprimatele de Irbesartan Hydrochlorothiazide BMS 150 mg/12,5 mg sunt disponibile în cutii cu blistere care conţin 14, 28, 56 sau 98 de comprimate.
English: Cartons of 98 tablets; 7 blister cards of 14 tablets in PVC/PVDC/Aluminium blisters.
Romanian: Cutie cu 98 comprimate, card cu 7 blistere din PVC/PVDC/Aluminiu a câte 14 comprimate.
English: What Irbesartan Hydrochlorothiazide BMS looks like and contents of the pack Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg film-coated tablets are pink, biconvex, ovalshaped, with a heart debossed on one side and the number 2788 engraved on the other side.
Romanian: Cum arată Irbesartan Hydrochlorothiazide BMS şi conţinutul ambalajului Comprimatele filmate de Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg sunt roz, biconvexe, ovale, având o inimă gravată pe o faţă şi numărul 2788 inscripţionat pe cealaltă faţă.
English: Cartons of 98 film-coated tablets; 7 blister cards of 14 film-coated tablets in PVC/PVDC/Aluminium blisters.
Romanian: Cutie cu 98 comprimate filmate, card cu 7 blistere din PVC/PVDC/Aluminiu a câte 14 comprimate filmate.
English: Cartons of 56 tablets; 4 blister cards of 14 tablets in PVC/PVDC/Aluminium blisters.
Romanian: Cutie cu 56 comprimate; card cu 4 blistere din PVC/PVDC/Aluminiu a câte 14 comprimate.
English: Irbesartan Hydrochlorothiazide BMS 300 mg/12.5 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets.
Romanian: Comprimatele de Irbesartan Hydrochlorothiazide BMS 300 mg/12,5 mg sunt disponibile în cutii cu blistere care conţin 14, 28, 56 sau 98 de comprimate.
English: Each tablet of Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg contains 150 mg irbesartan and 12.5 mg hydrochlorothiazide.
Romanian: Fiecare comprimat de Irbesartan Hydrochlorothiazide BMS 150 mg/12,5 mg conţine irbesartan 150 mg şi hidroclorotiazidă 12,5 mg.
English: Each film-coated tablet of Irbesartan Hydrochlorothiazide BMS 300 mg/12.5 mg contains 300 mg irbesartan and 12.5 mg hydrochlorothiazide.
Romanian: Fiecare comprimat filmat de Irbesartan Hydrochlorothiazide BMS 300 mg/12,5 mg conţine irbesartan 300 mg şi hidroclorotiazidă 12,5 mg.
English: Cartons of 56 film-coated tablets; 4 blister cards of 14 film-coated tablets in PVC/PVDC/Aluminium blisters.
Romanian: Cutie cu 56 comprimate filmate; card cu 4 blistere din PVC/PVDC/Aluminiu a câte 14 comprimate filmate.
English: Each film-coated tablet of Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg contains 150 mg irbesartan and 12.5 mg hydrochlorothiazide.
Romanian: Fiecare comprimat filmat de Irbesartan Hydrochlorothiazide BMS 150 mg/12,5 mg conţine irbesartan 150 mg şi hidroclorotiazidă 12,5 mg.
English: Each tablet of Irbesartan Hydrochlorothiazide BMS 300 mg/12.5 mg contains 300 mg irbesartan and 12.5 mg hydrochlorothiazide.
Romanian: Fiecare comprimat de Irbesartan Hydrochlorothiazide BMS 300 mg/12,5 mg conţine irbesartan 300 mg şi hidroclorotiazidă 12,5 mg.
English: PACKAGE LEAFLET: INFORMATION FOR THE USER Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg film-coated tablets irbesartan/hydrochlorothiazide
Romanian: PROSPECT: INFORMAŢII PENTRU UTILIZATOR Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg comprimate filmate irbesartan/hidroclorotiazidă
English: Irbesartan Hydrochlorothiazide BMS 300 mg/12.5 mg film-coated tablets are supplied in blister packs of 14, 28, 56, 84 or 98 film-coated tablets.
Romanian: Comprimatele filmate de Irbesartan Hydrochlorothiazide BMS 300 mg/12,5 mg sunt disponibile în cutii cu blistere care conţin 14, 28, 56, 84 sau 98 de comprimate filmate.
English: EU/1/06/369/006 - 14 tablets EU/1/06/369/007 - 28 tablets EU/1/06/369/008 - 56 tablets EU/1/06/369/009 - 56 x 1 tablets EU/1/06/369/010 - 98 tablets
Romanian: EU/1/06/369/006 - 14 comprimate EU/1/06/369/007 - 28 comprimate EU/1/06/369/008 - 56 comprimate EU/1/06/369/009 - 56 x 1 comprimate EU/1/06/369/010 - 98 comprimate
English: abnormal urination
Romanian: hipotensiune arterială ortostatică
English: EU/1/06/369/001 - 14 tablets EU/1/06/369/002 - 28 tablets EU/1/06/369/003 - 56 tablets EU/1/06/369/004 - 56 x 1 tablets EU/1/06/369/005 - 98 tablets
Romanian: EU/1/06/369/001 - 14 comprimate EU/1/06/369/002 - 28 comprimate EU/1/06/369/003 - 56 comprimate EU/1/06/369/004 - 56 x 1 comprimate EU/1/06/369/005 - 98 comprimate
English: Excipient:
Romanian: Litiu:
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 150 mg of irbesartan and 12.5 mg of hydrochlorothiazide.
Romanian: COMPOZIŢIA CALITATIVĂ ŞI CANTITATIVĂ Fiecare comprimat filmat conţine irbesartan 150 mg şi hidroclorotiazidă 12,5 mg. Excipient:
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 300 mg of irbesartan and 12.5 mg of hydrochlorothiazide.
Romanian: COMPOZIŢIA CALITATIVĂ ŞI CANTITATIVĂ Fiecare comprimat filmat conţine irbesartan 300 mg şi hidroclorotiazidă 12,5 mg. Excipient:
English: OTHER
Romanian: Du
English: NAME OF THE MEDICINAL PRODUCT Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg tablets irbesartan/hydrochlorothiazide
Romanian: DENUMIREA COMERCIALĂ A MEDICAMENTULUI Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg comprimate irbesartan/hidroclorotiazidă
English: What Irbesartan Hydrochlorothiazide BMS looks like and contents of the pack Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2775 engraved on the other side.
Romanian: Cum arată Irbesartan Hydrochlorothiazide BMS şi conţinutul ambalajului Comprimatele de Irbesartan Hydrochlorothiazide BMS 150 mg/12,5 mg sunt de culoarea piersicii, biconvexe, ovale, având o inimă gravată pe o faţă şi numărul 2775 inscripţionat pe cealaltă faţă.
English: What Irbesartan Hydrochlorothiazide BMS looks like and contents of the pack Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg film-coated tablets are peach, biconvex, ovalshaped, with a heart debossed on one side and the number 2875 engraved on the other side.
Romanian: Cum arată Irbesartan Hydrochlorothiazide BMS şi conţinutul ambalajului Comprimatele filmate de Irbesartan Hydrochlorothiazide BMS 150 mg/12,5 mg sunt culoarea piersicii, biconvexe, ovale, având o inimă gravată pe o faţă şi numărul 2875 inscripţionat pe cealaltă faţă.
English: CHINOIN PRIVATE CO. LTD. Lévai u.5.
Romanian: Lévai u.5.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 300 mg of irbesartan and 12.5 mg of hydrochlorothiazide.
Romanian: COMPOZIŢIA CALITATIVĂ ŞI CANTITATIVĂ Fiecare comprimat conţine irbesartan 300 mg şi hidroclorotiazidă 12,5 mg. Excipient:
English: NAME OF THE MEDICINAL PRODUCT Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg film-coated tablets irbesartan/hydrochlorothiazide
Romanian: DENUMIREA COMERCIALĂ A MEDICAMENTULUI Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg comprimate filmate irbesartan/hidroclorotiazidă
English: What Irbesartan Hydrochlorothiazide BMS looks like and contents of the pack Irbesartan Hydrochlorothiazide BMS 300 mg/12.5 mg tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2776 engraved on the other side.
Romanian: Cum arată Irbesartan Hydrochlorothiazide BMS şi conţinutul ambalajului Comprimatele de Irbesartan Hydrochlorothiazide BMS 300 mg/12,5 mg sunt de culoarea piersicii, biconvexe, ovale, având o inimă gravată pe o faţă şi numărul 2776 inscripţionat pe cealaltă faţă.
English: What Irbesartan Hydrochlorothiazide BMS looks like and contents of the pack Irbesartan Hydrochlorothiazide BMS 300 mg/12.5 mg film-coated tablets are peach, biconvex, ovalshaped, with a heart debossed on one side and the number 2876 engraved on the other side.
Romanian: Cum arată Irbesartan Hydrochlorothiazide BMS şi conţinutul ambalajului Comprimatele filmate de Irbesartan Hydrochlorothiazide BMS 300 mg/12,5 mg sunt culoarea piersicii, biconvexe, ovale, având o inimă gravată pe o faţă şi numărul 2876 inscripţionat pe cealaltă faţă.
English: PACKAGE LEAFLET: INFORMATION FOR THE USER Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg film-coated tablets irbesartan/hydrochlorothiazide
Romanian: PROSPECT: INFORMAŢII PENTRU UTILIZATOR Irbesartan Hydrochlorothiazide BMS 150 mg/12,5 mg comprimate filmate irbesartan/hidroclorotiazidă
English: NAME OF THE MEDICINAL PRODUCT Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg film-coated tablets irbesartan/hydrochlorothiazide
Romanian: DENUMIREA COMERCIALĂ A MEDICAMENTULUI Irbesartan Hydrochlorothiazide BMS 150 mg/12,5 mg comprimate filmate irbesartan/hidroclorotiazidă
English: NAME OF THE MEDICINAL PRODUCT Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg tablets irbesartan/hydrochlorothiazide
Romanian: DENUMIREA COMERCIALĂ A MEDICAMENTULUI Irbesartan Hydrochlorothiazide BMS 150 mg/12,5 mg comprimate irbesartan/hidroclorotiazidă
English: PACKAGE LEAFLET: INFORMATION FOR THE USER Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg tablets irbesartan/hydrochlorothiazide
Romanian: PROSPECT: INFORMAŢII PENTRU UTILIZATOR Irbesartan Hydrochlorothiazide BMS 150 mg/12,5 mg comprimate irbesartan/hidroclorotiazidă
English: PACKAGE LEAFLET: INFORMATION FOR THE USER Irbesartan Hydrochlorothiazide BMS 300 mg/12.5 mg tablets irbesartan/hydrochlorothiazide
Romanian: PROSPECT: INFORMAŢII PENTRU UTILIZATOR Irbesartan Hydrochlorothiazide BMS 300 mg/12,5 mg comprimate irbesartan/hidroclorotiazidă
English: PACKAGE LEAFLET: INFORMATION FOR THE USER Irbesartan Hydrochlorothiazide BMS 300 mg/12.5 mg film-coated tablets irbesartan/hydrochlorothiazide
Romanian: PROSPECT: INFORMAŢII PENTRU UTILIZATOR Irbesartan Hydrochlorothiazide BMS 300 mg/12,5 mg comprimate filmate irbesartan/hidroclorotiazidă
English: NAME OF THE MEDICINAL PRODUCT Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg film-coated tablets.
Romanian: DENUMIREA COMERCIALĂ A MEDICAMENTULUI Irbesartan Hydrochlorothiazide BMS 150 mg/12,5 mg comprimate filmate
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 150 mg of irbesartan and 12.5 mg of hydrochlorothiazide.
Romanian: COMPOZIŢIA CALITATIVĂ ŞI CANTITATIVĂ Fiecare comprimat conţine irbesartan 150 mg şi hidroclorotiazidă 12,5 mg. Excipient:
English: NAME OF THE MEDICINAL PRODUCT Irbesartan Hydrochlorothiazide BMS 300 mg/12.5 mg tablets irbesartan/hydrochlorothiazide
Romanian: DENUMIREA COMERCIALĂ A MEDICAMENTULUI Irbesartan Hydrochlorothiazide BMS 300 mg/12,5 mg comprimate irbesartan/hidroclorotiazidă
English: NAME OF THE MEDICINAL PRODUCT Irbesartan Hydrochlorothiazide BMS 300 mg/12.5 mg film-coated tablets irbesartan/hydrochlorothiazide
Romanian: DENUMIREA COMERCIALĂ A MEDICAMENTULUI Irbesartan Hydrochlorothiazide BMS 300 mg/12,5 mg comprimate filmate irbesartan/hidroclorotiazidă
English: NAME OF THE MEDICINAL PRODUCT Irbesartan Hydrochlorothiazide BMS 150 mg/12.5 mg tablets.
Romanian: DENUMIREA COMERCIALĂ A MEDICAMENTULUI Irbesartan Hydrochlorothiazide BMS 150 mg/12,5 mg comprimate
English: NAME OF THE MEDICINAL PRODUCT Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg film-coated tablets.
Romanian: DENUMIREA COMERCIALĂ A MEDICAMENTULUI Irbesartan Hydrochlorothiazide BMS 300 mg/25 mg comprimate filmate
English: dyspepsia, dysgeusia
Romanian: dispepsie, disgeuzie micţiune anormală
English: NAME OF THE MEDICINAL PRODUCT Irbesartan Hydrochlorothiazide BMS 300 mg/12.5 mg film-coated tablets.
Romanian: DENUMIREA COMERCIALĂ A MEDICAMENTULUI Irbesartan Hydrochlorothiazide BMS 300 mg/12,5 mg comprimate filmate
English: Other information about Biograstim:
Romanian: Alte informaţii despre Biograstim:
English: This means that Biograstim is similar to a biological medicine that is already authorised in the European Union (EU) and contains the same active substance (also known as the ‘reference medicine').
Romanian: Aceasta înseamnă că Biograstim este similar cu un medicament biologic care este deja autorizat în Uniunea Europeană (UE) şi care conţine aceeaşi substanţă activă (cunoscută şi sub denumirea de „medicament de referinţă”).
English: EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR) BIOGRASTIM EPAR summary for the public
Romanian: RAPORT EUROPEAN PUBLIC DE EVALUARE (EPAR) BIOGRASTIM Rezumat EPAR destinat publicului
English: Biograstim is used to stimulate the production of white blood cells in the following situations:
Romanian: Biograstim se utilizează pentru stimularea producerii globulelor albe în următoarele situaţii:
English: To study the safety of Biograstim, two further studies were carried out in patients with lung cancer and with non-Hodgkin's lymphoma.
Romanian: Pentru a studia siguranţa Biograstim, s-au efectuat alte două studii pe pacienţi cu cancer pulmonar şi cu limfom non-Hodgkin.